(Q39444397)

12 September 2017

title

CD80 (B7.1) is expressed on both malignant B cells and nonmalignant stromal cells in non-Hodgkin lymphoma (English)

1 reference

12 September 2017

3

Randy D Gascoyne

1 reference

12 September 2017

Naveen Dakappagari

1

1 reference

12 September 2017

Steffan N Ho

2

1 reference

12 September 2017

Julie Ranuio

4

1 reference

12 September 2017

Andrew P Weng

5

1 reference

12 September 2017

Shabnam Tangri

6

1 reference

12 September 2017

publication date

10 November 2011

1 reference

Cytometry Part B: Clinical Cytometry

12 September 2017

published in

1 reference

12 September 2017

volume

82

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

112-119

1 reference

Functional expression of B7/BB1 on activated T lymphocytes

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

Interaction of human PD-L1 and B7-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

Stromal gene signatures in large-B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

inferred from DOI database lookup

7 January 2021

based on heuristic

Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20631

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CYTO.B.20631

1 reference

12 September 2017

1 reference